We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.26B
AUM Growth
-$464M
Cap. Flow
+$97.5M
Cap. Flow %
4.32%
Top 10 Hldgs %
30.92%
Holding
158
New
12
Increased
35
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$50.6M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$28.2M
3
ZGNX
Zogenix, Inc.
ZGNX
+$21.7M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$18.7M
5
TWLO icon
Twilio
TWLO
+$17.9M

Top Sells

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$26.2M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$23.3M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$19.7M
4
SLDB icon
Solid Biosciences
SLDB
+$18.9M
5
SNA icon
Snap-on
SNA
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.75%
2 Technology 23.08%
3 Consumer Discretionary 10.05%
4 Industrials 6.38%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECYT
151
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-1,314,000
Closed -$23.3M
SEP
152
DELISTED
Spectra Engy Parters Lp
SEP
– –
-47,000
Closed -$1.68M
CELG
153
DELISTED
Celgene Corp
CELG
– –
-120,000
Closed -$10.7M
3 4 5 6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Eventide Asset Management held 158 positions worth $2.26B, down 17% from $2.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $97.5M of net new capital in Q4 2018, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Macquarie Infrastructure Holdings, LLC, an estimated $19.7M trimmed.

  • Eventide Asset Management's largest Q4 2018 buy was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.
  • Eventide Asset Management added most to Sage Therapeutics in Q4 2018, an estimated $50.6M increase.
  • Eventide Asset Management's biggest Q4 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $19.7M.
  • Eventide Asset Management fully exited AnaptysBio in Q4 2018, selling an estimated $26.2M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $2.26B portfolio in Q4 2018.
  • Eventide Asset Management opened 12 new positions and closed 24 in Q4 2018.
  • Eventide Asset Management's portfolio value fell 17% quarter-over-quarter to $2.26B.

Based on Eventide Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.